Skip to content

SAGE-Heart : Senior Assessment fraGility and Post-opErative QALYs 1 Year After Emergency HEART Surgery for Patients Aged 75 and Older

SAGE-Heart : Senior Assessment fraGility and Post-opErative QALYs 1 Year After Emergency HEART Surgery for Patients Aged 75 and Older

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07677319
Acronym
SAGE-Heart
Enrollment
265
Registered
2026-06-30
Start date
2025-12-03
Completion date
2028-12-03
Last updated
2026-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Surgery, Frailty, QALYs

Keywords

Frailty, Elderly, Cardiac Surgery, Cardio-pulmonary Bypass, QALYs, Clinical Frailty Scale, EuroQol, postoperative

Brief summary

The hypothesis is that the preoperative Clinical Frailty Score (CFS) is a predictive factor for a loss in quality-adjusted life years (QALYs) one year after emergency cardiac surgery under cardiopulmonary bypass (CPB) in patients aged 75 years and older.

Detailed description

The advancement of structural cardiology, particularly with percutaneous valve interventions, offers new treatment options without the need for cardiopulmonary bypass (CPB). Despite an increase in the use of these techniques, some studies highlight a notable rise in CPB usage in patients aged 80 and over, from 13.8% in 2013 to 20.5% in 2022. In France, the population aged 85 and above is expected to triple by 2050, meaning more elderly patients will be eligible for CPB cardiac surgery. Several global studies have examined the outcomes of older individuals undergoing CPB cardiac surgery. While EuroSCORE II and STS scores are effective in predicting short-term mortality, they lack accuracy in predicting long-term mortality, particularly in frail patients, and do not assess quality of life. New tools to evaluate frailty, such as the Clinical Frailty Scale (CFS), are now used in preoperative assessments for planned cardiac interventions. Identifying frail elderly patients early is crucial for improving patient and family information on care plans, especially in high-risk surgeries. Even in emergencies, patients must remain involved in their health decisions, and multidisciplinary collaboration is vital for improving postoperative recovery and quality of life. Data will be collected : * Preoperative: During the anesthesia consultation: Calculation of the CFS (frailty assessment = CFS ≥ 4) EuroQoL 5D-5L (quality of life, with the index calculated with the French value set of the EuroQol), and routine care (renal function: urea, creatinine, albumin levels). * Postoperative (ICU and hospital): Collection of complication incidence, mortality (all causes and LATA-related). * Follow-up (by phone at 3, 6, and 12 months): CFS and EuroQoL scores, prevalence of chronic pain and analgesic use, dialysis dependency, accommodation status, readmission rates, and death date if applicable.

Interventions

OTHERPhone Calls

Phone calls will be made at 3, 6, and 12 months to report quality of life scores (EuroQol EQ 5D-5L) and other postoperative data

Sponsors

University Hospital, Bordeaux
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
75 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients aged ≥ 75 years who are affiliated with or beneficiaries of a social security scheme and undergoing emergency cardiac surgery under cardiopulmonary bypass, either immediate or urgent (relative) : * Immediate emergency surgery: intervention performed before the start of the next working day following the decision to operate, * Urgent (relative) emergency surgery: patients not admitted electively for surgery but requiring an intervention during the current hospital stay for medical reasons, and who cannot be discharged without undergoing a definitive procedure

Exclusion criteria

* Patients requiring preoperative cardiopulmonary resuscitation * Scheduled (elective) surgery * Lack of informed consent * Impaired consciousness at the time of inclusion (defined by a Glasgow Coma Scale score \< 15) * Individuals under legal guardianship or judicial protection * Individuals participating in another interventional research protocol

Design outcomes

Primary

MeasureTime frameDescription
Quality-Adjusted Life Years (QALYs) according to preoperative frailty statusMonth 12QALYs over the 12-month follow-up will be estimated from EQ-5D-5L utility scores collected at baseline, Month 3, Month 6, and Month 12 together with survival data, and compared between participants with preoperative frailty (Clinical Frailty Scale ≥4) and those without frailty (Clinical Frailty Scale \<4), with adjustment for EuroSCORE II.

Secondary

MeasureTime frameDescription
Postoperative complicationsFrom surgery through,Day 28Incidence of postoperative cardiac, respiratory, renal, infectious, and neurological complications during the first 28 postoperative days.
All-cause mortalityThrough Month 12All-cause mortality assessed during ICU stay, hospital stay, and at Month 3, Month 6, and Month 12.
EQ-5D-5L Utility IndexBaseline, Month 3, Month 6, and Month 12Health-related quality of life assessed using the EQ-5D-5L utility index derived from the French value set
Dialysis dependenceMonth 3, Month 6, and Month 12Dialysis dependence among participants not receiving chronic dialysis before surgery.
Length of intensive care unit stayFrom ICU admission to ICU discharge (assessed up to Day 28)Duration of postoperative ICU stay.
Length of hospital stayFrom surgery to hospital dischargeTotal postoperative hospital length of stay.
Hospital readmissionsMonth 3, Month 6, and Month 12Number of hospital readmissions since discharge, assessed at each follow-up visit.
Chronic postoperative painMonth 3, Month 6, and Month 12Presence of chronic pain related to cardiac surgery.
Analgesic consumptionMonth 3, Month 6, and Month 12Type of analgesic medication and frequency of use since the previous follow-up assessment.
Living situationMonth 3, Month 6, and Month 12Living at home versus institutionalization during follow-up.
EQ-5D-5L visual analogue scale (EQ VAS)Baseline, Month 3, Month 6, and Month 12Self-rated health status assessed using the EQ-5D-5L visual analogue scale (0-100).

Countries

France

Contacts

CONTACTSimon CARRE, MD
simon.carre@chu-bordeaux.fr0556795679
PRINCIPAL_INVESTIGATORSimon CARRE, MD

University Hospital, Bordeaux

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 1, 2026